BIRC2 and central nervous system cancer: TRIM56 potentially promotes glioma development as a deubiquitinating enzyme of the apoptosis inhibitor cIAP1 (Fig. 7), thereby stabilizing the protein, inhibiting glioma cell apoptosis and promoting glioma cell proliferation.